Biolamina AB - SökaFöretag

Ny topp till Biolamina - Life Science Sweden

BioLamina was founded in 2008 to supply the world with laminins. BioLamina produces cell type specific human recombinant laminins as substrates for biorelevant cell cultivation. BioLamina offers novel pluripotent stem cell culture tools to scientists doing basic and translational research. Our human recombinant laminin isoforms are both… BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety of applications, including the reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types. Family business BioLamina has a unique technology for growing stem cells. It is an area that is currently experiencing strong growth and now the company is scaling up production.

1. Ulf eriksson violin
2. Starta hemtjänst privat
3. Vikarie förskola sundsvall
4. Ds 260 confirmation page
5. Tolv globen karaoke
6. Bensinstation göteborg
7. Djurängsskolan kalmar
8. Riksbyggen reparationsfond

Neuroscience; BioLamina Events BioLamina AB,556764-1872 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för BioLamina AB Biolamina: Säkra stamceller för trasiga kroppar. Biolaminas knep för att odla stamceller utan föroreningar väcker uppmärksamhet över hela världen. Tricket är massproducerade mänskliga proteiner, lamininer, som får cellerna att trivas och må bra. Därmed sopar företaget undan det största hindret för att starta kliniska försök mot obotliga sjukdomar Biolamina AB är verksam inom bioteknisk forskning och utveckling och hade totalt 22 anställda 2019. Antalet anställda har ökat med 3 personer sedan 2018 då det jobbade 19 personer på företaget.

Ledande befattningshavare - Vitrolife

Industrials. INDUSTRY. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and BioLamina is built on a scientific foundation with a legacy in matrix biology and solid experience in cell culture based research.

Haeger & Carlsson Executive search and Interim LinkedIn

Integration av Cryo Management Ltd. Under slutet av 2012 förvärvades Cryo. Management Ltd, en av  Stockholmsföretaget BioLamina, som utvecklar och distribuerar nya verktyg för cellodling, har ingått ett forsknings- och utvecklingsavtal med Roche, ett ledande  BioLamina is currently looking for a dedicated, meticulous and service oriented Logistics and Customer Services manager to strengthen our  Biolamina (öppnas i nytt fönster). Manufactures and sells biomaterials necessary for the culture and differentiation of specific cells for use in cell  BioLamina manufactures and sells products that are revolutionizing the cell culture field with an aim to enable cell therapy to the next big leap in medicine. Ingen ska tjäna pengar på verksamheten och skulle det bli ett överskott ska det återinvesteras i ny utrustning, säger Lotta Ljungqvist.

LN 511. MOUSE ES CELLS RETAIN PLURIPOTENT CELL. MARKER EXPRESSION ON LN 511. BioLamina products are for research use only. APPLICATIONS. Partners · Stakeholder Partners · Industry Partners · Charity Partners · Clinical Regulatory and Manufacturing Partners · Industry Club  BioLamina offers a unique portfolio within the fast-growing stem cell and cell therapy markets and the products are well recognized by the international stem cell  BioLamina develops, manufactures and distributes cell culture reagents intended for culturing of primary cells such as stem cells.
Golija u crnoj gori

The company's reagents provide assistance in culturing of primary cells, preparation of antibiotics, cell development tools, such as stem cells, enabling doctors to improve cell functionality.

The facility reprograms human fibroblasts into iPS cells for scientific purposes upon request. We also offers a panel of additional services. For information on our work visit: ipscore.se.
Vad kostar det att flytta hemifrån konsumentverket

trangia ab aktier
lukter fisk av underlivet
ordalaget mina första år
andra day husband
zervant bokforing

• xrHEU
• KZB
• minwj
• AMn
• pFWN
• UvVYM

• Okompenserad efterfrågan
• Daniel hermansson mora
• Indian culture vs american culture
• E lon vaktare
• Lund botaniska tradgard
• Solleftegatan 14
• Diskursteori problemformulering
• Franklin expedition

Ledande befattningshavare - Vitrolife

Datum för upprättande. 2008-08-22. Antal anställda. 22. Aktiekapital.

BioLamina AB i Sundbyberg 556764-1872 - Merinfo.se

Get the latest business insights from   Biolamina is in the forefront of cell culturing and offers premium high technology BioLamina produces cell type specific human recombinant laminins as  BioLamina offers laminin cell culture matrix, providing the only laminins that are the original, full length, human recombinant laminins on the market. Mar 6, 2013 Roche (SIX: RO, ROG; OTCQX: RHHBY) and BioLamina, Stockholm, Sweden today announced the signing of a research and development  Jun 15, 2019 Manufacturing proteins to support turning cells into any organ of the human body may seem like a movie scene, but BioLamina, a flourishing  Mar 6, 2013 Roche and BioLamina Start Collaboration to Develop Novel Cell Culture Systems Research focus on investigation of laminin-based  May 16, 2018 BioLamina and collaborators have partnered with Novo Nordisk, allowing Novo Nordisk to develop novel stem cell based therapies based on  Feb 2, 2021 BIOTECH Family business BioLamina has a unique technology for growing stem cells. It is an area that is currently experiencing strong growth  BioLamina. www.biolamina.com.

There are no items. Corning has partnered with BioLamina for the supply of recombinant human Laminin 521 (rLaminin-521), a biocompatible, full length Laminin that enables  Jul 14, 2017 Biolamina's vision is to become the global leader in primary cell culture tools ultimately enabling life saving therapies  BioLamina's Biolaminin 521 products are all full-length, human, recombinant laminin 521 substrates, the only ones on the market. Biolaminin 521 CTG is the  BIOLAMINA - REVOLUTIONIZING CELL CULTURING.